Clearing Up The Confusion: For Most, Statins Are Safe & Key To Cholesterol Control
February 25, 2026
As we end Heart Health month and perhaps renew our pledge to do all we can to lower our risk of heart disease (which continues to be the #1 cause of death in our country), there’s no getting around the risk that high cholesterol poses to our heart health. While…
Risks And Benefits: Understanding Your Risk of Falling And The Fall Prevention Benefits Of New Technologies
November 5, 2025
While aging itself is not a reason you’re at risk for falling, so many of the health and medical circumstances you face as an older adult do raise your risk. Consider some of these basic facts: From 1990-2021, there was a 182% increase in falls globally, with projections that the…
Deciphering Dementia: New Insights Into Lowering Your Risks
April 9, 2025
As research continues to push the boundaries of how we can treat various diseases that accompany aging, it’s also becoming apparent that these medical advances and innovations may also help us better understand and respond to the risk of dementia. In recent weeks, several major studies have demonstrated that treatments…
Evolving Advice: The Latest Insights Regarding Alzheimer’s Treatments
July 10, 2024
In the evolving landscape of the diagnosis and treatment of Alzheimer’s, updates and insights are regularly advancing. We’ve previously reported on the introduction and demise of the first breakthrough “treatment”- Aduhelm- and then on the introduction of Leqembi, the IV-administered antibody intended to slow down the pace of cognitive decline…
Espresso Yourself: What Is Coffee Doing For You?
July 10, 2024
Have you started your iced coffee routine yet this summer? For many, a nice iced coffee or cold brew (check out the difference between the two here) is just what it takes to get going on a summer morning. But that raises the perennial question: Is it okay to start…
Testing And Treating: The Latest Updates on Alzheimer’s Dementia
January 31, 2024
Last summer, we reported on the FDA approval of Leqembi, a medication that slows down cognitive decline in patients with Mild Cognitive Impairment or early Alzheimer’s Disease. While the medication is now covered by Medicare, patients who want access still have to demonstrate a diagnosis of Alzheimer’s and still have…